Table 2 RBC transfusion analysis

From: rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study

  RHuEpo recipients (s.d.) Controls (s.d.) P-value
Number of patients 11 17  
Number of transplant analyzed 15 22  
Transplant requiring transfusion 4/15 (26%) 21/22 (95%) 0.00001
Hb level at transplant (g/dl) 12.9 (2.2) 11.4 (1.5) 0.002
Hb level at discharge (g/dl) 9.9 (1.6) 9.9 (1.0) 0.9
Number of RBC unit transfused 1.2 (2.5) 3.3 (2.1) 0.006
rHuEpo responders
 Number of patients 9 17  
 Number of transplant analyzed 13 22  
 Transplant requiring transfusion 2/13 (15%) 21/22 (95%) 0.000002
 Hb level at transplant (g/dl) 13.7 (0.8) 11.4 (1.5) 0.000001
 Hb level at discharge 9.6 (1.6) 9.9 (1.0) 0.5
 Number of RBC unit transfused 0.3 (0.7) 3.3 (2.1) 0.00002
RBC according to pathology
 MM first transplant 1/7 (14%) 9/10 (90%) 0.003
 MM second transplant 1/4 5/5 0.04
 MCL 0/1 3/3 0.2
 Lymphoma (refractory/relapse) 2/3 4/4 0.4